Aurorium

What Aurorium does

Aurorium is a privately-held specialty ingredients and performance materials manufacturer organized as Aurorium Holdings LLC and headquartered in Indianapolis, Indiana. The company produces high-purity pharmaceutical excipients, buffers, reagents, and solvents — marketed under the Haelium™ brand — alongside industrial specialty chemicals for personal & home care, mobility, infrastructure, and paper & packaging end-markets. Its core differentiator is vertical integration: Aurorium operates four cGMP-certified manufacturing sites in North America and is the only vertically-integrated manufacturer of NF/USP-grade NaOH solutions on the continent, producing NaOH pellets, high-purity water, and Water For Injection on-site at its Midlothian, Texas facility. Additional branded product lines include Castorlatum™ (plant-based emollient), Xibond™ (mobility additives), Bersize™ (paper sizing), and Ultrium™ (aluminum can production). Aurorium serves pharmaceutical manufacturers — particularly in peptide/oligonucleotide (TIDES) synthesis, biologics, and vaccines — as well as industrial customers across personal care, automotive, construction, and packaging industries. The company maintains European representative operations in the UK, Austria, and the Netherlands.

Aurorium operates a B2B direct sales model with quote-based pricing to enterprise customers and is supported by technical content marketing and industry trade presence rather than self-service or channel distribution. Revenue mechanics are based on recurring and project-based specialty chemical product sales, with the pharmaceutical ingredients segment (Haelium™) positioned as the primary growth driver and the industrial segments providing diversification. The company is a Responsible Care® signatory and prioritizes regulatory compliance and supply-chain reliability as core value propositions, particularly for pharmaceutical customers requiring long qualification cycles and consistent pharmacopeia-grade quality. Leadership transitioned in December 2024 with the appointment of Faye Freeman as CEO.

Name

Aurorium

Legal name

Aurorium Holdings LLC

Website

https://www.aurorium.com/

Company type

Private

Founded year

1857

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Aurorium is a privately-held Indianapolis-based specialty ingredients manufacturer operating four cGMP-certified sites in North America, producing pharmaceutical excipients under its Haelium™ brand and industrial specialty chemicals for personal care, mobility, infrastructure, and paper & packaging customers worldwide.

Ownership category

akta.pro rank

Product category

Specialty Chemicals

NAICS

Chemical Manufacturing (325), Other Chemical Product and Preparation Manufacturing (3259), Other Basic Inorganic Chemical Manufacturing (325180), Metal Coating, Engraving (except Jewelry and Silverware), and Allied Services to Manufacturers (332812)

SIC

Miscellaneous Chemical Products (2890), Chemicals & Allied Products (2800), Industrial Inorganic Chemicals (2810), Industrial Organic Chemicals (2860)

akta.pro primary industry

Coating & Adhesive Raw Materials (Resins, Additives, Solvents) (IMAEAGAK)

akta.pro secondary industries

Personal Care & Cosmetic Ingredients (IMAEABAJ), Metal Packaging Coatings & Linings (BPA-NI, Epoxy, Internal Coatings) (IMALADAK), Packaging & Can Coatings (IMAEAGAF)

Keywords

• Specialty chemical manufacturing
• Pharmaceutical excipients
• Performance materials
• Personal care ingredients
• Industrial additives

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Ingredients & Excipients: Sale of specialty pharmaceutical ingredients including high-purity buffers, reagents, solvents, NaOH solutions, and other excipients to pharmaceutical manufacturers. Revenue generated through product sales with recurring demand from drug manufacturing customers.
2. Specialty Performance Materials: Sale of performance-enhancing specialty materials for personal & home care, mobility, infrastructure, and paper & packaging industries. Products include emollients, additives, and chemical solutions tailored to specific industrial applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Aurorium manufactures and sells specialty ingredients and performance-enhancing materials to industrial customers across healthcare, personal & home care, mobility, infrastructure, and paper & packaging. Its Haelium™ brand delivers high-purity pharmaceutical buffers, reagents, solvents, NaOH solutions, piperidine, extended-release coatings, and immunostimulants, while complementary brands include Castorlatum™ emollients, Xibond™ additives, Bersize™ ASA technology, and Ultrium™ aluminum can solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Haelium™: Pharmaceutical Solutions brand encompassing high-purity buffers, reagents, solvents, extended-release coatings, and immunostimulants for therapeutic areas including peptide and oligonucleotide production, large molecule biologics, vaccines, and oral solid dosage form.
• Xibond™
• Castorlatum™
• Bersize™
• Ultrium™

Products and services

• Haelium™ Pharmaceutical Solutions Comprehensive pharmaceutical ingredient brand encompassing high-purity buffers, reagents, solvents, extended-release coatings, and immunostimulants for therapeutic areas including peptide and oligonucleotide production, large molecule biologics, vaccines, and oral solid dosage forms. Built on four cGMP manufacturing sites in North America.
• Haelium™ Sodium Hydroxide Liquid (NaOH Solutions) Ready-to-use liquid NaOH solutions meeting U.S. and European Pharmacopeia (USP and EP) requirements, produced via vertically integrated manufacturing to eliminate additional preparation and minimize dust exposure risks.
• Haelium™ Piperidine High-purity reagent for manufacturing peptide-based therapeutics.
• Castorlatum™ Emollient Plant-based emollient serving as a sustainable alternative to petroleum jelly in personal care formulations such as skin care, lip care, and cosmetics.
• Xibond™ Additives Performance additives providing dimensional stability in demanding mobility environments such as automotive applications.
• Bersize™ ASA Technology Alkenyl Succinic Anhydride (ASA) technology driving efficiency in paper sizing applications for paper and packaging manufacturers.
• Ultrium™ 8900 Specialty solution unlocking efficiency and sustainability in aluminum can production.

Quantifiable outcome

• Reduced supply chain risk through vertical integration - produces NaOH pellets and solutions in-house rather than relying on third-party suppliers
• +2 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Innospec: Specialty chemicals company supplying performance additives, personal care actives, and fuel/oilfield chemicals — comparable mid-cap footprint to Aurorium, particularly in performance additives and personal care segments.
• Ashland: Specialty chemical company serving pharmaceuticals, personal care, and industrial markets with excipients, additives, and performance materials — comparable mid-scale footprint and end-market mix to Aurorium.
• Avantor: Avantor distributes and manufactures specialty chemicals and high-purity ingredients for pharmaceutical and life-science customers, directly overlapping Aurorium's Haelium™ excipients and NaOH/solvent portfolio.
• Croda International: Global specialty ingredients company focused on personal care, life sciences, and performance chemicals — directly comparable to Aurorium's Castorlatum™ emollient and personal/home care portfolio.
• EMD Millipore (MilliporeSigma): Life-science business of Merck KGaA supplying high-purity buffers, reagents, and solvents to pharma and biopharma — directly competes with Aurorium's Haelium™ pharmaceutical solutions in TIDES and biologics manufacturing.
• Lubrizol: Specialty chemicals producer with personal care ingredients, performance additives, and coatings — directly comparable to Aurorium's Castorlatum™, Xibond™, and Bersize™ product lines.

Others

• Evonik Industries: Large German specialty chemicals producer with extensive pharma excipients, personal care ingredients, and high-purity intermediates — overlaps with Aurorium across multiple verticals as a broad incumbent.

Broad incumbents

• Thermo Fisher Scientific (Patheon/CDMO chemicals): Through its chemicals and CDMO segments, Thermo Fisher supplies high-purity excipients and pharmaceutical ingredients to global drug manufacturers — overlapping with Aurorium's Haelium™ portfolio at much greater scale.
• BASF: World's largest chemical company with broad portfolios in pharma excipients, personal care ingredients, coatings, and packaging chemicals — competes with Aurorium across nearly every end-market at massive scale.
• Solvay: Belgian specialty chemicals major supplying soda ash/NaOH derivatives, high-purity reagents, and performance materials — overlapping with Aurorium's inorganic and pharmaceutical ingredient capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/vertellus
• YouTubeyoutube.com/@watch_aurorium
• Facebookfacebook.com/profile.php?id=61559613353064
• LinkedInlinkedin.com/company/aurorium
• Instagraminstagram.com/aurorium_specialty_ingredients

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aurorium